Table 1.
Weighted Prevalence (95% CI) | ||||||
---|---|---|---|---|---|---|
AI/AN | White | |||||
Year | AI/AN-High | AI/AN-Low | p Value | AI/AN-High | AI/AN-Low | p Value |
2019 | 20.7 (18.3–23.2) | 28.8 (24.9–33.0) | 0.001 | 18.4 (17.8–19.0) | 19.7 (19.4–20.0) | 4.12 × 10−4 |
2018 | 23.5 (20.6–26.6) | 31.8 (27.7–36.3) | 0.002 | 17.8 (17.2–18.4) | 19.3 (19.0–19.7) | 2.93 × 10−5 |
2017 | 20.9 (18.7–23.2) | 31.5 (27.8–35.4) | 1.55 × 10−6 | 17.5 (16.9–18.1) | 19.3 (18.9–19.6) | 4.67 × 10−7 |
2016 | 22.4 (19.9–25.1) | 26.2 (23.1–29.5) | NS (0.079) | 16.7 (16.2–17.2) | 18.4 (18.1–18.7) | 1.60 × 10−7 |
2015 | 19.7 (17.0–22.8) | 31.2 (27.8–34.9) | 8.48 × 10−7 | 17.3 (16.8–17.9) | 18.5 (18.2–18.8) | 3.93 × 10−4 |
2014 | 19.9 (17.9–22.2) | 28.4 (25.1–32.0) | 2.41 × 10−5 | 16.7 (16.2–17.2) | 18.3 (18.0–18.6) | 3.07 × 10−8 |
2013 | 22.5 (19.6–25.7) | 28.1 (24.7–31.7) | 0.019 | 17.2 (16.6–17.8) | 18.4 (18.1–18.7) | 4.57 × 10−4 |
2012 | 19.0 (16.8–21.3) | 28.8 (25.3–32.5) | 2.47 × 10−6 | 15.5 (15.1–16.0) | 17.2 (16.9–17.5) | 8.14 × 10−9 |
2011 | 19.9 (17.4–22.7) | 24.9 (21.8–28.3) | 0.019 | 16.3 (15.7–16.8) | 17.6 (17.3–17.8) | 8.43 × 10−5 |
p Value: p values were obtained using the Rao–Scott χ2 test. NS: not significant.